Leila Zarif

1.3k total citations
37 papers, 1.0k citations indexed

About

Leila Zarif is a scholar working on Organic Chemistry, Molecular Biology and Biomaterials. According to data from OpenAlex, Leila Zarif has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 12 papers in Molecular Biology and 11 papers in Biomaterials. Recurrent topics in Leila Zarif's work include Hemoglobin structure and function (7 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Lipid Membrane Structure and Behavior (6 papers). Leila Zarif is often cited by papers focused on Hemoglobin structure and function (7 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Lipid Membrane Structure and Behavior (6 papers). Leila Zarif collaborates with scholars based in France and United States. Leila Zarif's co-authors include Jean G. Riess, David S. Perlin, Raphael J. Mannino, Bernard Pucci, André A. Pavia, John R. Graybill, Gilles Delmas, Jacques Greiner, Rosie Bocanegra and Laura K. Najvar and has published in prestigious journals such as Advanced Materials, Journal of Controlled Release and Journal of Medicinal Chemistry.

In The Last Decade

Leila Zarif

36 papers receiving 978 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leila Zarif France 18 346 256 222 190 152 37 1.0k
Jacques Greiner France 18 338 1.0× 481 1.9× 215 1.0× 80 0.4× 80 0.5× 63 929
M. A. Alsina Spain 19 965 2.8× 211 0.8× 62 0.3× 68 0.4× 176 1.2× 134 1.5k
Òscar Domènech Spain 24 895 2.6× 129 0.5× 137 0.6× 93 0.5× 74 0.5× 68 1.6k
T. Eric Ballard United States 24 924 2.7× 632 2.5× 45 0.2× 202 1.1× 81 0.5× 40 1.9k
Christopher Kirby United Kingdom 18 1.0k 3.0× 133 0.5× 262 1.2× 44 0.2× 439 2.9× 28 1.8k
Maria Luisa Gelmi Italy 25 1.0k 2.9× 1.3k 5.0× 182 0.8× 72 0.4× 309 2.0× 171 2.2k
Andreas Kerth Germany 21 934 2.7× 307 1.2× 111 0.5× 36 0.2× 157 1.0× 41 1.3k
Sergey N. Mikhailov Russia 22 1.1k 3.3× 426 1.7× 64 0.3× 277 1.5× 133 0.9× 179 1.8k
Miklós Nagy Hungary 16 196 0.6× 297 1.2× 23 0.1× 108 0.6× 57 0.4× 93 934
Sven Even Borgos Norway 21 448 1.3× 110 0.4× 85 0.4× 76 0.4× 212 1.4× 36 1.0k

Countries citing papers authored by Leila Zarif

Since Specialization
Citations

This map shows the geographic impact of Leila Zarif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Zarif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Zarif more than expected).

Fields of papers citing papers by Leila Zarif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila Zarif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Zarif. The network helps show where Leila Zarif may publish in the future.

Co-authorship network of co-authors of Leila Zarif

This figure shows the co-authorship network connecting the top 25 collaborators of Leila Zarif. A scholar is included among the top collaborators of Leila Zarif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila Zarif. Leila Zarif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zarif, Leila. (2005). Drug Delivery by Lipid Cochleates. Methods in enzymology on CD-ROM/Methods in enzymology. 391. 314–329. 49 indexed citations
2.
Zarif, Leila & Raphael J. Mannino. (2002). Cochleates. Advances in experimental medicine and biology. 465. 83–93. 16 indexed citations
3.
Delmas, Gilles, et al.. (2002). Efficacy of Orally Delivered Cochleates Containing Amphotericin B in a Murine Model of Aspergillosis. Antimicrobial Agents and Chemotherapy. 46(8). 2704–2707. 87 indexed citations
4.
Zarif, Leila. (2002). Elongated supramolecular assemblies in drug delivery. Journal of Controlled Release. 81(1-2). 7–23. 87 indexed citations
5.
Segarra, Ignacio, et al.. (2002). Pharmacokinetics and tissue distribution after intravenous administration of a single dose of amphotericin B cochleates, a new lipid‐based delivery system. Journal of Pharmaceutical Sciences. 91(8). 1827–1837. 43 indexed citations
6.
Voiglio, Eric J., Leila Zarif, Marie Pierre Krafft, et al.. (1996). Aerobic Preservation of Organs Using a New Perflubron/Lecithin Emulsion Stabilized by Molecular Dowels. Journal of Surgical Research. 63(2). 439–446. 13 indexed citations
7.
Polidori, Ange, Bernard Pucci, Leila Zarif, Jean G. Riess, & André A. Pavia. (1996). Effect of polymerization of synthetic glycolipids on their supramolecular assemblies. Macromolecular Rapid Communications. 17(4). 229–238. 8 indexed citations
8.
Voiglio, Eric J., Leila Zarif, F. Gorry, et al.. (1994). Normothermic Preservation of “Multiple Organ Blocks” with a New Perfluorooctyl Bromide Emulsion. Artificial Cells Blood Substitutes and Biotechnology. 22(4). 1455–1461. 3 indexed citations
9.
10.
Riess, Jean G., et al.. (1994). Novel Fluorocarbon-Based Injectable Oxygen-Carrying Formulations with Long-Term Room-Temperature Storage Stability. Advances in experimental medicine and biology. 345. 227–234. 39 indexed citations
11.
Zarif, Leila, et al.. (1994). Novel Injectable Fluorinated Contrast Agents with Enhanced Radiopacity. Artificial Cells Blood Substitutes and Biotechnology. 22(4). 1421–1428. 7 indexed citations
12.
Pucci, Bernard, et al.. (1994). Vesicles and other supramolecular systems from biocompatible synthetic glycolipids with hydrocarbon and/or fluorocarbon chains. Chemistry and Physics of Lipids. 72(2). 153–173. 25 indexed citations
13.
Zarif, Leila, et al.. (1994). Double-Tailed Perfluoroalkylated Glycolipids as Components for Drug Delivery and Targeting Systems. Preliminary Biocompatibility Results. Artificial Cells Blood Substitutes and Biotechnology. 22(4). 1485–1490. 5 indexed citations
14.
Zarif, Leila, et al.. (1994). Biodistribution and Excretion of a Mixed Fluorocarbon-Hydrocarbon “Dowel” Emulsion as Determined by 19 F NMR. Artificial Cells Blood Substitutes and Biotechnology. 22(4). 1193–1198. 9 indexed citations
15.
Zarif, Leila, Jean G. Riess, Bernard Pucci, & André A. Pavia. (1993). Biocompatibility of Alkyl and Perfluoroalkyl Telomeric Surfactants Derived from Tham. Biomaterials Artificial Cells and Immobilization Biotechnology. 21(5). 597–608. 12 indexed citations
16.
Riess, Jean G., André A. Pavia, Bernard Pucci, & Leila Zarif. (1992). Telomeric Tham-Derived Perfluoroalkylated Surfactants for Fluorocarbon Emulsions. Biomaterials Artificial Cells and Immobilization Biotechnology. 20(2-4). 843–844. 2 indexed citations
17.
Valla, Alain, et al.. (1992). Perfluoroalkylated Surfactants: Relationships Between Structure and Acute Toxicity in Mice. Biomaterials Artificial Cells and Immobilization Biotechnology. 20(2-4). 1025–1027. 5 indexed citations
18.
Zarif, Leila, et al.. (1990). Synthesis of perfluoroalkylated xylitol ethers and esters: new surfactants for biomedical uses. Journal of Medicinal Chemistry. 33(4). 1262–1269. 45 indexed citations
19.
Zarif, Leila, Jacques Greiner, & Jean G. Riess. (1989). Perfluoroalkylated monoesters of 1,4-D-sorbitan, isosorbide and isomannide: new surfactants for biomedical applications. Journal of Fluorine Chemistry. 44(1). 73–85. 25 indexed citations
20.
Riess, Jean G., et al.. (1988). Design, Synthesis and Evaluation of Fluorocarbons and Surfactants for in Vivo Applications New Perfluoroalkylated Polyhydroxylated Surfactants. Biomaterials Artificial Cells and Artificial Organs. 16(1-3). 421–430. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Greiner Breakdown of academic impact, for papers by M. A. Alsina Breakdown of academic impact, for papers by Òscar Domènech Breakdown of academic impact, for papers by T. Eric Ballard Breakdown of academic impact, for papers by Christopher Kirby Breakdown of academic impact, for papers by Maria Luisa Gelmi Breakdown of academic impact, for papers by Andreas Kerth Breakdown of academic impact, for papers by Sergey N. Mikhailov Breakdown of academic impact, for papers by Miklós Nagy Breakdown of academic impact, for papers by Sven Even Borgos
Rankless by CCL
2026